Please use this identifier to cite or link to this item:
|Title:||Latent tuberculosis infection screening and treatment in HIV: insights from evaluation of UK practice.|
|Authors:||White, Helena A .|
Miller, R. F.
Pozniak, A. L.
Lipman, M. C.
Wiselka, Martin J.
|Publisher:||BMJ Publishing Group, British Thoracic Society (BTS)|
|Abstract:||Latent TB infection (LTBI) screening and treatment in HIV-positive individuals in the UK is advocated by the British HIV Association (BHIVA) and National Institute for Health and Care Excellence (NICE), although each recommends differing strategies. We undertook an evaluation of UK practice, relating the responses to the local HIV/TB disease burden. 162 of 188 (86%) UK geographical areas responded; only 93/162 (57.4%) offer LTBI testing with considerable heterogeneity in practice, and no difference in HIV/TB burden between areas offering testing and those who do not. Only 33/93 (35.5%) and 6/93 (6.5%) reported full compliance with BHIVA and NICE guidance respectively. A uniform national guideline is required.|
|Rights:||Creative Commons “Attribution Non-Commercial No Derivatives” licence CC BY-NC-ND, further details of which can be found via the following link: http://creativecommons.org/licenses/by-nc-nd/4.0/ Archived with reference to SHERPA/RoMEO and publisher website.|
|Description:||Additional material is published online only. To view please visit the journal online (http://dx.doi.org/10. 1136/thoraxjnl-2016-209063)|
|Appears in Collections:||Published Articles, Dept. of Infection, Immunity and Inflammation|
Files in This Item:
|LTBIHIVscreeningmanuscript260816 (1).pdf||Post-review (final submitted author manuscript)||476.07 kB||Adobe PDF||View/Open|
Items in LRA are protected by copyright, with all rights reserved, unless otherwise indicated.